Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia

NCT07732907 · clinicaltrials.gov ↗

RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis
Progressive Multifocal Leukoencephalopathy

Interventions

DRUG: Ozanimod

Sponsor

Bristol-Myers Squibb